13F-HR filed by Checkpoint Capital L.P.
Checkpoint Capital L.P. filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 17 holding rows worth $149,628,625.
- Accession
- 0001977548-24-000006
- Filer
- CIK 1977548
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 17 entries on the cover page, a total value of $149,628,625 stated on the cover page (in dollars after the unit check, H1), rows summing to $149,628,625 with VALUE read as dollars as filed, 13F file number 028-23869. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 825,500 | $35,768,915 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 82,000 | $32,285,040 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 190,000 | $13,320,900 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 701,387 | $11,846,426 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 132,437 | $10,568,473 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 362,193 | $9,098,288 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 280,301 | $8,109,108 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 273,776 | $6,896,417 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 618,528 | $5,387,379 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 445,161 | $4,727,610 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 1,446,477 | $2,820,630 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 168,739 | $1,991,120 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 185,653 | $1,979,061 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 506,082 | $1,745,983 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 220,000 | $1,496,000 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 767,964 | $967,635 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 892,853 | $619,640 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001977548-24-000006 | this filing | 2024-05-15 | acceptance time not in the bulk data set |